No Data
No Data
Estimating The Fair Value Of MicroPort CardioFlow Medtech Corporation (HKG:2160)
CARDIOFLOW-B: 2024 Interim Report
Sinocare Ltd. - B (02160) fell 42.40%, now trading at HKD 0.600, hitting a 52-week low.
As of 11:46, Xin Tong Medical - B (02160) fell 42.40% from the previous closing price, now at 0.600 yuan, hitting a 52-week low; the volume of transactions was 2.324 million shares, with a transaction value of 1.3961 million Hong Kong dollars.
Xintong Medical-B (02160.HK): The revenue in the first half of the year reached 0.223 billion yuan, a year-on-year increase of 26.5%.
Gelonghui August 28th | Sinocare Medical -B (02160.HK) announced that as of June 30, 2024, the group recorded revenue of 0.223 billion yuan, a year-on-year increase of 26.5%, mainly due to the increase in hospital admissions in China for the group's TAVI products and surgical accessories, promoting sales growth. At the same time, during the reporting period, the continued advancement of VitaFlow Liberty and AlwidePlus in global commercialization also contributed to the growth of overseas income. In addition, during the reporting period, the group's subsidiary Shanghai Zuoxin independently developed
Express News | Microport Cardioflow Medtech Corp H1 Revenue RMB 223.1 Million
Express News | Microport Cardioflow Medtech Corp H1 Capex RMB 5.4 Million
No Data
No Data